We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





New Electronic-Based ‘Nose’ Detector Sniffs out COVID-19-Infected People in 80 Seconds

By LabMedica International staff writers
Posted on 03 Jun 2021
A proof of concept with an electronic nose has suggested that an optimized detector may allow effective real-time diagnosis of SARS CoV-2 infection, which would provide for extensive relief in the COVID-19 pandemic.

A group of scientists at the Weizmann Institute of Science (Rehovot, Israel) successfully deployed a mobile eNose platform that can smell SARS CoV-2 infection at a drive-through testing station.

Rapid diagnosis is the key to curtailing the COVID-19 pandemic. More...
One path to such rapid diagnosis may rely on identifying volatile organic compounds (VOCs) emitted by the infected body, or in other words, identifying the smell of the infection. Consistent with this rationale, dogs can use their nose to identify COVID-19 patients. Given the scale of the pandemic, however, animal deployment is a challenging solution.

In contrast, electronic noses (eNoses) are machines aimed at mimicking animal olfaction, and these can be deployed at scale. To test the hypothesis that there is a body-odor, and more specifically an intra-nasal-passage body-odor, associated with SARS CoV-2 infection detectable by eNose, the scientists placed a generic eNose in-line at a drive-through testing station. The team applied a deep learning classifier to the eNose measurements, and achieved real-time detection of SARS CoV-2 infection at a level significantly better than chance, for both symptomatic and non-symptomatic participants.

Given the current results with a generic eNose, the scientists speculate that an optimized eNose may be able to provide effective real-time diagnoses in locations such as airports, the work-place, and cultural events, and in this potentially contribute to social and economic recovery in the COVID-19 pandemic.

Related Links:
Weizmann Institute of Science


Platinum Member
Fully Automatic ACLIA Analyzer
MAGLUMI X8
Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Clinical Informatics Platform
CLARION™
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.